12454840

Source:http://linkedlifedata.com/resource/pubmed/id/12454840

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019163, umls-concept:C0030705, umls-concept:C0209738, umls-concept:C0369332, umls-concept:C0392756, umls-concept:C0524909, umls-concept:C0971023, umls-concept:C1282910
pubmed:dateCreated	2002-11-27
pubmed:abstractText	Entecavir is a novel and selective nucleoside analogue with potent activity against hepatitis B virus (HBV).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12454840-12454868
pubmed:language	eng
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Guanine, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/entecavir
pubmed:status	MEDLINE
pubmed:author	pubmed-author:AndersonFrank HFH, pubmed-author:DehertoghDeborahD, pubmed-author:LaiChing-LungCL, pubmed-author:LaoJudyJ, pubmed-author:RosmawatiMohamedM, pubmed-author:ThomasNealN, pubmed-author:Van VlierbergheHansH
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1831-8
pubmed:dateRevised	2006-11-15
pubmed:articleTitle	Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
pubmed:affiliation	Department of Medicine, Queen Mary Hospital, Hong Kong, China. hrmelcl@hkucc.hku.hk